30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
The Supreme Court of the United States kicked off its 2019-2020 term on October 7, 2019, with severa...
Read More >
From September 27, 2019, through October 6, 2019, the International Association of Athletics Federat...
Read More >
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
Let's dispel some myths. Force majeure clauses do not always relieve a party of its obligations. Not...
Read More >
Last week, in Frlekin v. Apple, Inc., the California Supreme Court held that employee exit searches ...
Read More >
When a private equity (PE) firm acquires a closely held business, it is quite common for the seller ...
Read More >